Marine Biotechnology
Marine Biotechnology exploits the diversity found in marine environments in terms of the form, structure, physiology and chemistry of marine organisms, many of which have no equivalent on land, in ways which enable new materials to be realised. Marine biotechnology is a knowledge generation and conversion process: it unlocks access to biological compounds and provides novel uses for them. By exploring and harnessing marine materials, entirely new uses in areas far from the marine are likely to be found.
Marine biotechnology techniques-
- Bioprocessing
- Bioharvesting
- Bioprospecting
- Bioremediation
Related Conference of Marine Biotechnology
June 29-30, 2026
41st International Conference on Next-Gen Biotechnology and Applications
Aix-en-Provence, France
Marine Biotechnology Conference Speakers
Recommended Sessions
- Agricultural Biotechnology
- Analytical Biotechnology
- Animal Biotechnology
- Biochemical Engineering
- Biotechnology
- Environmental Biotechnology
- Genetics and Molecular Biotechnology
- Industrial Biotechnology
- Marine Biotechnology
- Medical Biotechnology
- Microbial Biotechnology
- Stem Cell Biotechnology and Regenerative Medicine
- Tissue Engineering
Related Journals
Are you interested in
- Advancements in Analytical Techniques - ANALYTICA ACTA 2026 (France)
- Advancements in Biosimilar Development Technologies - Biosimilars 2026 (France)
- Advances in Genomic Biotechnology - Biotechnology 2025 (Spain)
- Agricultural Biotechnology & Crop Improvement - Biotechnology- 2026 (Germany)
- Agriculture Biotechnology - Euro Biotechnology 2026 (Italy)
- Analytical Challenges in Personalized Medicine - ANALYTICA ACTA 2026 (France)
- Analytical Chemistry in Agriculture - ANALYTICA ACTA 2026 (France)
- Analytical Chemistry in the Energy Sector - ANALYTICA ACTA 2026 (France)
- Analytical Techniques and Laboratory Methods - BIOMEDICINE 2026 (Italy)
- Analytical Techniques for Biotechnology - ANALYTICA ACTA 2026 (France)
- Analytical Techniques in Material Science - ANALYTICA ACTA 2026 (France)
- Animal Biotechnology - Euro Biotechnology 2026 (Italy)
- Artificial Intelligence and Digital Tools in Biotherapeutics - Biosimilars 2026 (France)
- Artificial Intelligence in Drug Discovery and Pharmacotherapy - BIOMEDICINE 2026 (Italy)
- Automation in Bioanalytical Laboratories - ANALYTICA ACTA 2026 (France)
- Bio-Safety and Bioethics - Euro Biotechnology 2026 (Italy)
- Bioanalytical Method Development and Validation - ANALYTICA ACTA 2026 (France)
- Biobetters: The Next Generation of Biologics - Biosimilars 2026 (France)
- Bioinformatics & Computational Biology - Euro Biotechnology 2026 (Italy)
- Bioinformatics & Computational Biology - Biotechnology- 2026 (Germany)
- Bioinformatics and Computational Approaches - ANALYTICA ACTA 2026 (France)
- Biomaterials - Euro Biotechnology 2026 (Italy)
- Biomedical Biotechnology - Biotechnology 2025 (Spain)
- Biomedical Engineering & Applications - Euro Biotechnology 2026 (Italy)
- Biopharmaceutical Development - Biotechnology- 2026 (Germany)
- Biopharmaceuticals and Biologics - ANALYTICA ACTA 2026 (France)
- Biopharmaceuticals and Biosimilars - Biotechnology 2025 (Spain)
- Bioprocess and Fermentation Technology - Euro Biotechnology 2026 (Italy)
- Bioremediation and Biodegradation - Euro Biotechnology 2026 (Italy)
- Biosimilar Market Access and Reimbursement Policies - Biosimilars 2026 (France)
- Biosimilars in Oncology and Autoimmune Diseases - Biosimilars 2026 (France)
- Biosimilars in Rare and Orphan Diseases - Biosimilars 2026 (France)
- Biotechnology - Euro Biotechnology 2026 (Italy)
- Biotechnology and Global Health - Biotechnology 2025 (Spain)
- Biotechnology Applications - Euro Biotechnology 2026 (Italy)
- Biotechnology in Agriculture - Biotechnology 2025 (Spain)
- Biotechnology in Dentistry - Euro Biotechnology 2026 (Italy)
- Cardiovascular Pharmacotherapy - BIOMEDICINE 2026 (Italy)
- Chemical Analysis and Sensing - ANALYTICA ACTA 2026 (France)
- Clinical and Forensic Analysis - ANALYTICA ACTA 2026 (France)
- Clinical Pharmacology and Therapeutics - BIOMEDICINE 2026 (Italy)
- Clinical Trials & Comparability Studies for Biosimilars - Biosimilars 2026 (France)
- Clinical Trials and Translational Research - BIOMEDICINE 2026 (Italy)
- Collaborative Models in Biosimilar Development - Biosimilars 2026 (France)
- Computational and Systems Biology - Biotechnology 2025 (Spain)
- Cost-Effectiveness and Health Economics of Biosimilars - Biosimilars 2026 (France)
- CRISPR & Gene Therapy Applications - Biotechnology- 2026 (Germany)
- Data Integrity and Compliance in Analytical Chemistry - ANALYTICA ACTA 2026 (France)
- Drug Discovery and Development - BIOMEDICINE 2026 (Italy)
- Emerging Contaminants and Analytical Challenges - ANALYTICA ACTA 2026 (France)
- Emerging Therapies and Innovative Drugs - BIOMEDICINE 2026 (Italy)
- Emerging Trends in Analytical and Bioanalytical Techniques - ANALYTICA ACTA 2026 (France)
- Environmental & Green Biotechnology - Biotechnology- 2026 (Germany)
- Environmental Analysis - ANALYTICA ACTA 2026 (France)
- Environmental Biotechnology - Biotechnology 2025 (Spain)
- Environmental Biotechnology - Euro Biotechnology 2026 (Italy)
- Enzyme and Protein Engineering - Euro Biotechnology 2026 (Italy)
- Evolving Trends and Innovations in Biosimilar Development and Access - Biosimilars 2026 (France)
- Food and Beverage Analysis - ANALYTICA ACTA 2026 (France)
- Food and Feed Biotechnology - Euro Biotechnology 2026 (Italy)
- Formulation and Delivery Systems for Biologics - Biosimilars 2026 (France)
- Future Biotherapeutics: Cell and Gene Therapies - Biosimilars 2026 (France)
- Future of Monoclonal Antibodies and Fusion Proteins - Biosimilars 2026 (France)
- Future Trends in Biotechnology - Biotechnology 2025 (Spain)
- Genetic Engineering & Genome Editing - Biotechnology- 2026 (Germany)
- Genetics and Molecular biotechnology - Euro Biotechnology 2026 (Italy)
- Genomics and Molecular Biology Analysis - ANALYTICA ACTA 2026 (France)
- Global Trends and Challenges in Biosimilar Adoption - Biosimilars 2026 (France)
- High-Resolution Techniques - ANALYTICA ACTA 2026 (France)
- Imaging Techniques and Microscopy - ANALYTICA ACTA 2026 (France)
- Immunobiology and Immunotherapy in Biomedicine - BIOMEDICINE 2026 (Italy)
- Immunogenicity Assessment and Risk Management - Biosimilars 2026 (France)
- Immunotherapy and Biologics - BIOMEDICINE 2026 (Italy)
- Industrial and Manufacturing Biotechnology - Euro Biotechnology 2026 (Italy)
- Industrial Biotechnology - Biotechnology 2025 (Spain)
- Industrial Biotechnology & Bioprocessing - Biotechnology- 2026 (Germany)
- Industrial Scale-Up and Bioprocessing - Biotechnology 2025 (Spain)
- Instrumentation and Automation in Analytical Chemistry - ANALYTICA ACTA 2026 (France)
- Interchangeability and Substitution Policies - Biosimilars 2026 (France)
- Manufacturing and Quality Control of Biosimilars - Biosimilars 2026 (France)
- Marine Biotechnology - Biotechnology 2025 (Spain)
- Marine Biotechnology - Euro Biotechnology 2026 (Italy)
- Medical Biotechnology - Euro Biotechnology 2026 (Italy)
- Metabolomics and Proteomics - ANALYTICA ACTA 2026 (France)
- Microbial Biotechnology - Biotechnology 2025 (Spain)
- Microbial Biotechnology - Euro Biotechnology 2026 (Italy)
- Microbial Biotechnology & Fermentation - Biotechnology- 2026 (Germany)
- Molecular Diagnostics & Biomarkers - Biotechnology- 2026 (Germany)
- Molecular Diagnostics and Biomarker Discovery - BIOMEDICINE 2026 (Italy)
- Molecular Medicine and Genetics - BIOMEDICINE 2026 (Italy)
- Nano Biotechnology - Euro Biotechnology 2026 (Italy)
- Nanobiotechnology & Drug Delivery - Biotechnology- 2026 (Germany)
- Nanobiotechnology in Biomedicine - BIOMEDICINE 2026 (Italy)
- Nanomaterials and Nanotechnology in Analysis - ANALYTICA ACTA 2026 (France)
- Nanomedicine and Drug Delivery Systems - BIOMEDICINE 2026 (Italy)
- Nanotechnology Applications in Pharmacotherapy - BIOMEDICINE 2026 (Italy)
- Natural Products and Phytopharmacology - BIOMEDICINE 2026 (Italy)
- Neuropharmacology and Central Nervous System Therapies - BIOMEDICINE 2026 (Italy)
- Oncology Pharmacotherapy - BIOMEDICINE 2026 (Italy)
- Oncolytic Biotechnology - Euro Biotechnology 2026 (Italy)
- Patient and Physician Perspectives on Biosimilar Use - Biosimilars 2026 (France)
- Pediatric and Geriatric Pharmacotherapy - BIOMEDICINE 2026 (Italy)
- Personalized & Precision Medicine - Biotechnology- 2026 (Germany)
- Pharmaceutical Analysis - ANALYTICA ACTA 2026 (France)
- Pharmaceutical Biotechnology and Drug Design - Euro Biotechnology 2026 (Italy)
- Pharmacogenomics and Personalized Medicine - BIOMEDICINE 2026 (Italy)
- Pharmacovigilance and Drug Regulation - BIOMEDICINE 2026 (Italy)
- Pharmacovigilance and Post-Marketing Surveillance - Biosimilars 2026 (France)
- Plant and Forest Biotechnology - Euro Biotechnology 2026 (Italy)
- Quality by Design (QbD) in Analytical Method Development - ANALYTICA ACTA 2026 (France)
- Regenerative Medicine and Analytical Techniques - ANALYTICA ACTA 2026 (France)
- Regenerative Medicine and Cell Therapy - BIOMEDICINE 2026 (Italy)
- Regulatory Pathways and Global Harmonization - Biosimilars 2026 (France)
- Spectroscopic Techniques - ANALYTICA ACTA 2026 (France)
- Stem Cell and Regenerative Medicine - Biotechnology 2025 (Spain)
- Stem Cell Biotechnology and Regenerative Medicine - Euro Biotechnology 2026 (Italy)
- Stem Cell Innovations - Biotechnology- 2026 (Germany)
- Stem Cell Therapy and Regenerative Biomedicine - BIOMEDICINE 2026 (Italy)
- Surface and Interface Analysis - ANALYTICA ACTA 2026 (France)
- Synthetic & Systems Biology - Biotechnology- 2026 (Germany)
- Synthetic Biology and Bioengineering - Biotechnology 2025 (Spain)
- Systems Pharmacology and Computational Biology - BIOMEDICINE 2026 (Italy)
- Tissue Engineering & Regenerative Medicine - Biotechnology- 2026 (Germany)
- Toxicology and Safety Assessment - BIOMEDICINE 2026 (Italy)
- Translational Biotechnology & Commercialization - Biotechnology- 2026 (Germany)
- Vaccine Development and Immunotherapy - Biotechnology 2025 (Spain)
- Workshops and Hands-On Training - ANALYTICA ACTA 2026 (France)